Goldman M - Search Results

1

Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.

Roufosse F, de Lavareille A, Schandené L, Cogan E, Georgelas A, Wagner L, Xi L, Raffeld M, Goldman M, Gleich GJ, Klion A. Roufosse F, et al. Among authors: goldman m. J Allergy Clin Immunol. 2010 Oct;126(4):828-835.e3. doi: 10.1016/j.jaci.2010.06.049. J Allergy Clin Immunol. 2010. PMID: 20810155 Free PMC article. Clinical Trial.

2

High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.

de Lavareille A, Roufosse F, Schmid-Grendelmeier P, Roumier AS, Schandené L, Cogan E, Simon HU, Goldman M. de Lavareille A, et al. Among authors: goldman m. J Allergy Clin Immunol. 2002 Sep;110(3):476-9. doi: 10.1067/mai.2002.127003. J Allergy Clin Immunol. 2002. PMID: 12209097

3

The hypereosinophilic syndrome revisited.

Roufosse F, Cogan E, Goldman M. Roufosse F, et al. Among authors: goldman m. Annu Rev Med. 2003;54:169-84. doi: 10.1146/annurev.med.54.101601.152431. Epub 2001 Dec 3. Annu Rev Med. 2003. PMID: 12525672 Review.

4

Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.

Roufosse F, Goldman M, Cogan E. Roufosse F, et al. Among authors: goldman m. Semin Respir Crit Care Med. 2006 Apr;27(2):158-70. doi: 10.1055/s-2006-939519. Semin Respir Crit Care Med. 2006. PMID: 16612767 Review.

5

Hypereosinophilic syndromes.

Roufosse FE, Goldman M, Cogan E. Roufosse FE, et al. Among authors: goldman m. Orphanet J Rare Dis. 2007 Sep 11;2:37. doi: 10.1186/1750-1172-2-37. Orphanet J Rare Dis. 2007. PMID: 17848188 Free PMC article. Review.

6

Lymphocytic variant hypereosinophilic syndromes.

Roufosse F, Cogan E, Goldman M. Roufosse F, et al. Among authors: goldman m. Immunol Allergy Clin North Am. 2007 Aug;27(3):389-413. doi: 10.1016/j.iac.2007.07.002. Immunol Allergy Clin North Am. 2007. PMID: 17868856 Review.

7

Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo.

de Lavareille A, Roufosse F, Schandené L, Stordeur P, Cogan E, Goldman M. de Lavareille A, et al. Among authors: goldman m. Eur J Immunol. 2001 Apr;31(4):1037-46. doi: 10.1002/1521-4141(200104)31:4<1037::aid-immu1037>3.0.co;2-#. Eur J Immunol. 2001. PMID: 11298328 Free article.

8

Recent advances in pathogenesis and management of hypereosinophilic syndromes.

Roufosse F, Cogan E, Goldman M. Roufosse F, et al. Among authors: goldman m. Allergy. 2004 Jul;59(7):673-89. doi: 10.1111/j.1398-9995.2004.00465.x. Allergy. 2004. PMID: 15180753 Review.

9

Hypereosinophilic syndrome induced by neonatal immunization against MHC class II alloantigen: critical role of IL-4.

Le Moine A, Flamand V, de Lavareille A, Paulart F, Buonocore S, Vanderhaeghen ML, Nagy N, Habran C, Kiss R, Abramowicz D, Goldman M. Le Moine A, et al. Among authors: goldman m. Eur J Immunol. 2002 Jan;32(1):174-81. doi: 10.1002/1521-4141(200201)32:1<174::AID-IMMU174>3.0.CO;2-L. Eur J Immunol. 2002. PMID: 11754358 Free article.

10

6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.

Ravoet M, Sibille C, Roufosse F, Duvillier H, Sotiriou C, Schandené L, Martiat P, Goldman M, Willard-Gallo KE. Ravoet M, et al. Among authors: goldman m. Haematologica. 2005 Jun;90(6):753-65. Haematologica. 2005. PMID: 15951288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,344 results

Search Page